World Health Organization

Antimicrobial resistance could kill 39 million people over 25 years: WHO | World Health Organization News

UN’s health agency says growing resistance to antibiotics and other medicines are threatening the ‘future of modern medicine’.

The World Health Organization (WHO) has warned that growing antimicrobial resistance could cause 39 million deaths over the next 25 years as it threatens to make routine surgery and childbirth life-threatening.

Senior officials from the United Nations health agency said on Monday progress in prevention, diagnosis and the appropriate use of antibiotics remained too slow to meet global targets.

Recommended Stories

list of 3 itemsend of list

“Antibiotic resistance – but broadly, we are talking about antimicrobial resistance, or AMR – is widespread and threatening the future of modern medicine,” Jean-Pierre Nyemazi, acting director of the WHO’s AMR department, told a virtual conference of the 6th Annual Global Media Forum on AMR.

“Unlike COVID-19, which was very visible, drug-resistant infections have been taking people’s lives for years without us noticing it and raising the alarm as we should,” he said.

In 2021 alone, it was directly responsible for more than one million deaths and linked to about 4.7 million others, according to WHO figures.

National action plans

An investigation into the progress of the fight against antimicrobial resistance in 183 countries this year revealed that nearly nine in 10 countries had a national action plan against the phenomenon. In 2017, the figure was just about four in 10.

Pravasha Prakash, an AMR technical officer with the global health agency, said only 42 countries – less than one in five – had a plan that was financed, implemented and monitored.

“Countries are moving forward in every step, but progress still needs to be speeded up to reach the 2030 targets,” she added.

The latest global surveillance data show that, in 2023, one in every six laboratory-confirmed bacterial infections flagged to the WHO was resistant to antibiotics used to treat it.

Sylvia Bertagnolo, head of surveillance for AMR at the WHO, said, “Without testing, clinicians must treat without knowing the cause of infection or which antibiotic will work.”

The WHO announced the release of two new tools designed to help countries strengthen diagnostic capabilities.

The first defines the tests that should be available at every level of the healthcare system, from primary care centres to referral hospitals.

The second compiles 73 laboratory procedures, from sample collection to the identification of pathogens and antibiotic susceptibility testing.

The agency added that infection prevention, vaccination, improved access to water and sanitation, and the appropriate use of antimicrobials are the main levers to combat the issue.

Source link

WHO announces start of Ebola vaccine clinical trial in DR Congo | World Health Organization News

The World Health Organization (WHO) has announced the beginning of the first clinical trial of an Ebola vaccine in the outbreak that started in the Democratic Republic of Congo (DRC).

WHO’s director-general, Tedros Adhanom Ghebreyesus, said in a social media post on Friday that participants in the trial were vaccinated with the Ervebo vaccine in Bunia, the capital of the DRC’s northeastern Ituri province, which is the epicentre of the Ebola outbreak.

Recommended Stories

list of 3 itemsend of list

Ervebo, a vaccine approved for use against the more common Zaire strain of Ebola, will be put through a full-scale human trial to see if it offers any cross-protection against the Bundibugyo species of Ebola that is behind the epidemic.

“This trial will help us understand whether any of the vaccine candidates designed for Bundibugyo virus work,” the WHO chief said on X.

“WHO is supporting this DRC-led effort to find answers and save lives,” he added.

The DRC declared its 17th and worst-ever Ebola outbreak in May and has since reported more than 9,700 cases, with the number of deaths exceeding 4,600.

The WHO, in response, triggered a public health emergency of international concern, its second-highest alert level.

The current outbreak has now been reported in four countries across eastern, central ⁠⁠and western Africa, giving it the widest geographic spread of any Ebola outbreak on the continent to date.

Vaccines in the pipeline

The so-called Tumaini trial is a single trial framework that can test the safety, efficacy and immunogenicity of multiple vaccines.

The trial will use a ring vaccination approach: immunising contacts deemed to be at high risk of infection.

The trial is set to incorporate two Bundibugyo-specific candidate vaccines, which are currently advancing through earlier-stage, smaller-scale clinical trials.

One is a ChAdOx1 adenoviral vector jab being developed by the University of Oxford; the other, by the US-based Moderna group, uses mRNA technology.

Both have received funding from the Coalition for Epidemic Preparedness Innovations and are expected to enter the trial “shortly”, CEPI said in a statement.

The trial will include pregnant women and children aged 12 years and older, generating evidence for populations that are often excluded from clinical trials.

WHO emergencies director Chikwe Ihekweazu said the trial was set up to generate the rigorous evidence needed to determine whether the participating vaccines could protect people at risk.

Source link

Kenya confirms eighth Ebola case amid widening regional outbreak | Ebola News

Kenyan health authorities say latest patient was likely exposed to the country’s first Ebola case.

Kenyan health authorities say an eighth Ebola case has been detected, bringing the total number of known infections in the East African nation to eight.

Director-General for Health Patrick Amoth told Kenya’s Citizen TV that of the 38 people tested on Sunday, one had returned a positive result.

Recommended Stories

list of 3 itemsend of list

“He is a 49-year-old man who is not a healthcare worker. He developed fever, headache and muscle pain,” he said.

Amoth said the man, who worked as a patient attendant cleaning utensils and linens, was likely exposed to Kenya’s first Ebola case, discovered earlier this month.

He developed symptoms on Saturday, was quarantined and tested for the virus, a Ministry of Health source said.

The ministry reported four new cases on Saturday, three of whom were health workers who treated the country’s first Ebola patient, a man who travelled from the Democratic Republic of the Congo (DRC) to Nairobi and died at a Nairobi hospital on October 5.

In a post on X, the ministry said the fourth person was related to the deceased patient.

Travellers walk at the Kenya immigration services to access port health services at the Busia One Stop Border Post, crossing-point between Kenya and Uganda, after a man who had been living in the Democratic Republic of Congo travelled and died of a new Ebola outbreak involving the Bundibugyo species at the Nairobi Hospital, in Busia, Kenya October 8, 2026 [James Keyi/Reuters]
Travellers enter Kenya’s immigration services to access port health services at the Busia One Stop Border Post, a crossing point between Kenya and Uganda, in Busia, Kenya, on October 8, 2026 [James Keyi/Reuters]

Kenya has been on heightened alert, as the Ebola outbreak has spilled across the border from the DRC. The current outbreak is of the Bundibugyo strain of the virus, for which there is no vaccine or specific treatment.

The DRC has recorded at least 9,400 cases, including more than 4,500 deaths, in the deadliest outbreak in the country’s history, which started in May.

Ituri province in eastern DRC remains the disease’s epicentre, accounting for almost three quarters of confirmed cases, according to the government’s most recent data. It announced on Sunday that the virus has reached an eighth province, North Ubangi.

State-run news agency ACP reported on Sunday that authorities in North Kivu province, where the World Health Organization said substantial transmission continues, are introducing a one-week ban from Monday on people entering the province from Ituri in an effort to slow the spread.

Other measures set to be introduced include restrictions on passenger numbers in cars and on motorbikes and suspension of large public gatherings.

Neighbouring Uganda recorded 20 confirmed cases, including 15 imported from the DRC, and two deaths, before it was declared Ebola-free in August.

Source link